论文部分内容阅读
据北京大学人民医院风湿免疫科博士李春最近研究结果:类风湿治疗应遵循下列原则:早期积极用药目前公认的类风湿关节炎治疗的国际共识可归纳为以下三方面。一、早期给予抗风湿药(DMARD)。早期用药可使类风湿关节炎患者的病情在发病的起始阶段得到控制。一项为期11年的前瞻性研究证明,在早期活动性类风湿关节炎患者中,联合应用或单用DMARD可使部分患者的病情显著改善,并获得较
According to Li Chun, a professor of Rheumatology and Immunology at Peking University People’s Hospital, recent research results show that rheumatoid arthritis treatment should follow the following principles: Early active drug use Currently recognized international consensus on the treatment of rheumatoid arthritis can be summarized into the following three aspects. First, given early anti-rheumatic drugs (DMARD). Early treatment of patients with rheumatoid arthritis can be the initial stage of disease control. A 11-year prospective study demonstrated that in patients with early-stage active rheumatoid arthritis, either combined or with DMARD alone significantly improved the condition of some patients and achieved better outcomes than